Bone targeted drugs 1. Identification of heterocycles with hydroxyapatite affinity

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 9, 1996, Pages 1043-1046

  Willson, Timothy M ^a   Charifson, Paul S ^a   Baxter, Anthony D ^b   Geddie, Nora G ^a  

^a GLAXOSMITHKLINE   (United States)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 4 PYRAZOLECARBOXYLIC ACID; HYDROXYAPATITE; ISOTHIAZOLE DERIVATIVE; ISOXAZOLE DERIVATIVE; PYRAZOLE DERIVATIVE; TETRACYCLINE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BONE; CALCIUM BINDING; DRUG SYNTHESIS; DRUG TARGETING; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

EID: 0029906351     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-894X(96)00164-3     Document Type: Article

References (14)

1. Mundy, G. R.; Martin, T, J. Physiology and Pharmacology of Bone; Springer-Verlag: Berlin, 1993.
2. Kanis, J. A. Bone 1995, 17, 101S.
3. Jarvis, M. F.; Burns, C. J.; Pauls, H. W.; Assal, A.; Kim, J. S.; Cheney, D. L.; Youssefyeh, R. D. Calcif. Tissue Int. 1993, 52, 372.
4. Gorbunoff, M. A. Anal. Biochem. 1984, 136, 425.
5. Myers, H. M. Calcif Tissue Int. 1987, 40, 344.
6. Ross, J. M.; Smith, W. C. J. Am. Chem. Soc. 1964, 86, 2861.
7. 14C]-1 to rats, 6% of the radioactivity remained in the carcass. Autoradiography showed specific labelling of the bones: McCulloch, R. J.; Willmot, P. I. (Histopathology Department, Glaxo Group Research, Ware, UK), unpublished results.
8. Weiler, E. D.; Hausman, M.; Miller, G. A. J. Hetercycl. Chem. 1977, 14, 725.
9. Wieland, H.; Kitasato, Z.; Utzino, S. Liebigs Ann. Chem. 1930, 478, 43.
10. Aki, O.; Kawakita, K.; Matsushita, Y.; Morimoto, A.; Ochiai, M.; Okada, T. US Patent 4 098 888, 1993
11. Silverman, R. B. J. Heterocycl. Chem. 1978, 15, 1519.
12. Bowden, K.; Crank, G.; Ross, W. J. J. Chem. Soc., C 1968, 172.
13. 1 for the carboxylate anion of 2 and 5 respectively.
14. Taylor, N.; Cook, R. T. Tetrahedron 1987, 43, 607.